Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Schizophr Res. 2018 Apr 5;199:285–291. doi: 10.1016/j.schres.2018.03.037

Figure 2.

Figure 2

Effects of memantine on A: PPI; B: MMN; C, D: ASSR in HS and SZ patients. SZ patients and HS (n’s=42 & 42) were tested after placebo or memantine (20 mg p.o. shown here). Memantine significantly enhanced PPI (Swerdlow et al. 2016) (A; p<0.04 for 10–120 ms; p<0.01 for 60 ms), MMN (Swerdlow et al. 2016) (B; p<0.014; Duration; Pitch; Combined) and ASSR (Light et al. 2017) (C: Evoked Power, 40 Hz *p<0.025; D: Gamma Phase Locking (Coherence), *p<0.002). Figure modified and reproduced from Swerdlow et al. (2016) and Light et al. (2017).